Dow Wolff Cellulosics Unveils FYI: Formulation Yields Innovation, a Groundbreaking Initiative Focusing on the Role of Excipient Design and Formulation in Addressing Key Mark...
Dow Wolff Cellulosics (DWC) today launched “FYI: Formulation Yields Innovationâ€, a new program highlighting the importance of the design and formulation of pharmaceutical excipients in driving the innovation of new or enhanced products. FYI will include transformational internal initiatives and collaborative customer programs designed to elevate and accentuate excipients in addressing key market needs.
“The role of inactive ingredients, coatings, controlled release technologies, and matrix systems is becoming more important as companies face their biggest challenges: cost and time pressures, product safety considerations, and product life-cycle demands,†said Lucrèce Foufopoulos, Global Marketing Director, Dow Wolff Cellulosics. “The launch of the ‘FYI: Formulation Yields Innovation’ initiative will allow DWC to extend the impact of our technical expertise and portfolio of products to help our customers achieve a range of formulation advances.â€
“FYI: Formulation Yields Innovation" is built upon the following three main pillars that are central to addressing the challenges that DWC’s customers face:
- Value Creation/Cost Containment: In the highly competitive and increasingly global pharmaceutical market, there is mounting pressure on research and development (R&D) programs to shorten development time and get products to market faster. This demand results in the need for high-performance functional excipients and advanced film coating solutions. DWC helps drug manufacturers create significant efficiencies, improve formulation and delivery flexibility, and support cost containment â€" all of which add value to their business and to the customers they serve.
